Hiroki Izumi Selected Research

Hiroki Izumi Research Topics

8	Neoplasms (Cancer) 01/2021 - 01/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 04/2015
5	Lung Neoplasms (Lung Cancer) 11/2021 - 03/2014
4	Adenocarcinoma of Lung 12/2021 - 03/2014
3	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2015
2	Squamous Cell Carcinoma of Head and Neck 11/2021 - 01/2020
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2014 - 01/2010
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Cholangitis 11/2019
1	Acute-Phase Reaction 01/2018
1	Fever (Fevers) 12/2017
1	Malaria 05/2017
1	Pulmonary Emphysema 01/2017
1	Pathologic Complete Response 12/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2016
1	Respiratory Insufficiency (Respiratory Failure) 04/2015
1	Pain (Aches) 01/2013
1	Hyperalgesia 01/2013
1	Breast Neoplasms (Breast Cancer) 05/2011
1	Granuloma 01/2010
1	Pulmonary Sarcoidosis 01/2010
1	Sarcoidosis (Schaumann Disease) 01/2010

4	ErbB Receptors (EGF Receptor)IBA 01/2017 - 03/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2021 - 04/2015
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 03/2014
2	Zoledronic Acid (Zometa)FDA Link 01/2018 - 12/2017
1	RNA (Ribonucleic Acid)IBA 01/2021
1	osimertinibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 11/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019
1	NivolumabIBA 11/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2019
1	NitrogenIBA 12/2017
1	Diphosphonates (Bisphosphonates)IBA 12/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2017
1	Vincristine (Oncovin)FDA LinkGeneric 12/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2016
1	Prednisolone (Predate)FDA LinkGeneric 12/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2016
1	Rituximab (Mabthera)FDA Link 12/2016
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2015
1	amrubicinIBA 03/2014
1	Formaldehyde (Formol)FDA Link 01/2013
1	Substance PIBA 01/2013
1	L 644711 (B-3(+))IBA 01/2010

2	Therapeutics 12/2021 - 05/2017
2	Drug Therapy (Chemotherapy) 03/2015 - 01/2010
1	Castration 01/2020
1	Precision Medicine 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 03/2015
1	Radiotherapy 05/2011
1	Solid-State Lasers 01/2011
1	Surgical Instruments (Clip) 01/2011